Skip to main content

Breaking news: Brendon McCullum commits to New Zealand

Having trouble viewing this email? Click here
MyBLACKCAPS
   

Member: MBC3970144

 
Brendon McCullum
 
Brendon McCullum commits to New Zealand
 

BLACKCAPS captain Brendon McCullum has committed himself to New Zealand Cricket for another year, and will lead the team in the long-awaited home and away series against Australia this summer, as well as being available for the World T20 in India in March.

 

Read full story 

 
 
 
 
Mike Sandle
 
Mike Sandle reflects on England Tour
 
We caught up with BLACKCAPS Team Manager Mike Sandle on his highs and lows of the England tour. 
 
 
 
 
Old Trafford video
 
BLACKCAPS visit Old Trafford
 
During their tour of England, some of the BLACKCAPS were lucky enough to visit the home of Manchester United Football Club - Old Trafford.  See what they got up to.
 
 
 
 
 
Andrew Mathieson
Interview: Andrew Mathieson
 
Newest BLACKCAP Andrew Mathieson talks to us about being called up to play in the 5th ODI of the UK tour, and his first wicket.
 
 
 
 
 
 
If you no longer wish to receive our emails, click the link below:
Unsubscribe
 
 
New Zealand Cricket Level 3, 8 Nugent Street Grafton, Auckland 1023 New Zealand (649) 972-0605


Comments

Post a Comment

Popular posts from this blog

The first drug for a common, deadly liver disease is here – and more are coming

VIEW IN BROWSER | SUBSCRIBE TUE, MAR 19, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.   Good morning!  Millions of Americans with a common and potentially life-threatening form of liver disease will soon have access to the first-ever treatment for the condition.    In a landmark decision on Thursday, the Food and Drug Administration approved Madrigal Pharmaceuticals ' drug " Rezdiffra ," to be used along with diet and exercise. The company expects the medicine to be available next month with a hefty price tag of $47,400 per year before insurance and other rebates.    So, why is this approval so important?    First of all, people suffering from the disease badly need a treatment. Rezdiffra is specifically approved to treat patients with nonalcoholic steatoh
Post a Comment
Read More

J&J, Merck and Bristol Myers Squibb are in the hot seat

VIEW IN BROWSER | SUBSCRIBE TUE, JAN 30, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.   Good afternoon! This is Annika Kim Constantino, and I cover the biotech and pharmaceutical industry for CNBC.com .    Three names in the industry – Johnson & Johnson, Merck and Bristol Myers Squibb – face a pivotal few weeks ahead.    CEOs from those companies are slated to testify at a Senate hearing on high prescription drug prices in the U.S. on Feb. 8 at 10 a.m. ET, Sen. Bernie Sanders announced Friday.   It took subpoena threats from the senator, but J&J CEO Joaquin Duato and Merck CEO Robert Davis have agreed to testify after both executives declined earlier requests to appear at the Senate HELP committee's hearing. They join Bristol Myers Squibb CEO Chris Boerner, who agr
Post a Comment
Read More

Israel activates evacuation plan for 28 communities along Lebanon border

To keep you updated, we send Defence News to your mailbox. In case, you wish to Unsubscribe Click Here Defence News Dear Reader, Just catching up? Here are the top
Post a Comment
Read More